Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

被引:0
|
作者
Anders, Hans J. [1 ]
Rovin, Brad H. [2 ]
Zhao, Ming Hui [3 ]
Malvar, Ana [4 ]
Hiromura, Keiju [5 ]
Jones-Leone, Angela R. [6 ]
Gonzalez-Rivera, Tania [6 ]
Gilbride, Jennifer A. [7 ]
Madan, Anuradha [6 ]
Green, Yulia [8 ]
Roth, David A. [6 ]
机构
[1] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Peking Univ First Hosp, Beijing, Peoples R China
[4] Org Med Invest, Buenos Aires, DF, Argentina
[5] Gunma Univ, Grad Sch Med, Dept Nephrol & Rheumatol, Maebashi, Gumma, Japan
[6] GlaxoSmithKline, Collegeville, PA USA
[7] GlaxoSmithKline, Stevenage, Herts, England
[8] GlaxoSmithKline, Brentford, England
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
SA-OR32
引用
收藏
页码:48 / 49
页数:2
相关论文
共 50 条
  • [1] Effect of belimumab in renal function and proteinuria in patients with lupus nephritis (LN): our experience
    Liebana, Marc Patricio
    Romeo, Maria Jose Soler
    Hernandez, Josefina Cortes
    Gabaldon, Maria Alejandra
    Carrillo, Jorge Ivan Zamora
    Lopez, Marina
    Borda, Jhusel Rosas
    Garcia, Sheila Bermejo
    Berna, Gerson
    Leon, Juan Carlos
    Matamoros, Oriol Bestard
    Pamplona, Irene Agraz
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [2] Effect of belimumab in renal function and proteinuria in patients with lupus nephritis (LN): our experience
    Patricio Liebana, Marc
    Soler Romeo, Maria Jose
    Cortes Hernandez, Josefina
    Alejandra Gabaldon, Maria
    Zamora Carrillo, Jorge Ivan
    Lopez, Marina
    Rosas Borda, Jhusel
    Bermejo Garcia, Sheila
    Berna, Gerson
    Carlos Leon, Juan
    Bestard Matamoros, Oriol
    Agraz Pamplona, Irene
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I651 - I651
  • [3] Efficacy and Safety of Belimumab in Refractory and Newly Diagnosed Patients with Active Lupus Nephritis: A Real-World Retrospective Observational Study
    Ma, Ying
    Lu, Wanhong
    Sun, Jiping
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [4] Pure Membranous Lupus Nephritis (LN) and Renal Outcomes
    Larned, Catherine
    Gordon, Sarah M.
    Olson, Stephen W.
    Nee, Robert
    Costa, Gillian
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 488 - 488
  • [5] A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
    Rovin, Brad H.
    Furie, Richard
    Teng, Y. K. Onno
    Contreras, Gabriel
    Malvar, Ana
    Yu, Xueqing
    Ji, Beulah
    Green, Yulia
    Gonzalez-Rivera, Tania
    Bass, Damon
    Gilbride, Jennifer
    Tang, Chun-Hang
    Roth, David A.
    KIDNEY INTERNATIONAL, 2022, 101 (02) : 403 - 413
  • [6] BONE DISEASE IN NEWLY DIAGNOSED LUPUS NEPHRITIS PATIENTS
    Resende, Aline
    Dias, Cristiane Bitencourt
    Dos Reis, Luciene
    Jorgetti, Vanda
    Woronik, Viktoria
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 156 - 157
  • [7] Bone Disease in Newly Diagnosed Lupus Nephritis Patients
    Resende, Aline Lazara
    dos Reis, Luciene Machado
    Dias, Cristiane Bitencourt
    Custodio, Melani Ribeiro
    Jorgetti, Vanda
    Woronik, Viktoria
    PLOS ONE, 2014, 9 (09):
  • [8] Belimumab may not prevent lupus nephritis in serologically active patients with ongoing non-renal disease activity
    Sjowall, C.
    Coster, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (05) : 428 - 430
  • [9] Prediction of Renal Outcomes in Patients With Crescentic Lupus Nephritis
    Chen, Shasha
    Tang, Zheng
    Zhang, Haitao
    Hu, Weixin
    Liu, Zhihong
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 349 (04): : 298 - 305
  • [10] Antiphospholipid Antibodies and Renal Outcomes in Patients with Lupus Nephritis
    Tsuruta, Yuki
    Uchida, Keiko
    Itabashi, Mitsuyo
    Yumura, Wako
    Nitta, Kosaku
    INTERNAL MEDICINE, 2009, 48 (21) : 1875 - 1880